Latest Internal Medicine News

Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.

Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology) at Yale School of Medicine, is quoted in an article on the next wave of weight-loss drugs.

Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine, discusses the importance of consulting a multidisciplinary tumor board when making treatment decisions for patients with non–small cell lung cancer (NSCLC), as well as the optimal treatment course for patients with stage III, EGFR-mutated disease.

Barbara Burtness, MD, Anthony N. Brady Professor of Medicine (Medical Oncology), Chief Translational Research Officer at Yale Cancer Center, and Chief of Head and Neck Cancers/Sarcoma, and Maryam Lustberg, MD, MPH, Associate Professor of Internal Medicine (Medical Oncology) and Chief of Breast Medical Oncology, have been named Fellows of the American Society of Clinical Oncology (FASCO).

Patients with respiratory failure who require invasive mechanical ventilation for extended periods of time may require a tracheostomy, a ventilatory mechanism through the trachea. Acute myocardial infarction patients require an antiplatelet regimen to thin the blood and prohibit clumping in the arteries. This antiplatelet regimen often cannot be stopped and may increase the risk of bleeding from tracheostomy.

More than 70,000 Medicare beneficiaries receive care in long-term acute care hospitals for prolonged medical illnesses such as dependence on the ventilator after pneumonia. Very little has been known about their long-term functional and cognitive outcomes after hospitalization.

For more than 25 years, innovative research on health conditions specifically affecting women, more prevalent in women, or affecting women differently than men has been at the core of Women’s Health Research at Yale.

This April, Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and Professor of Dermatology and Molecular, Cellular, and Developmental Biology, and of Epidemiology at Yale, was named to the TIME100 by TIME Magazine.

Scott Roberts, MD, assistant professor of medicine (infectious diseases) at Yale School of Medicine, discusses how changes in the rodent population may lead to a higher risk of human exposure to the hantavirus.